During the past decade, Oklahoma Heart Institute conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 23 clinical trials were completed, i.e. on average, 71.9% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 13 clinical trials were completed. i.e. 118.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oklahoma Heart Institute" #1 sponsor was "Abbott Medical Devices" with 9 trials, followed by "Medtronic Cardiac Rhythm and Heart Failure" with 8 trials sponsored, "Edwards Lifesciences" with 5 trials sponsored, "Biosense Webster, Inc." with 2 trials sponsored and "Boston Scientific Corporation" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oklahoma Heart Institute" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Albany Stratton VA Medical Center" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Biosense Webster, Inc." with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Oklahoma Heart Institute" are "Heart Failure" (7 trials), "Atrial Fibrillation" (4 trials), "Cardiovascular Diseases" (4 trials), "Arrhythmia" (3 trials) and "Mitral Regurgitation" (3 trials). Many other conditions were trialed in "Oklahoma Heart Institute" in a lesser frequency.

Most popular intervention types in "Oklahoma Heart Institute" are "Device" (37 trials), "Drug" (14 trials), "Other" (4 trials), "Procedure" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "HeartWare Ventricular Assist Device" (2 trials), "Abbott Mitraclip System" (1 trials), "Accent MRI system (lead safety)" (1 trials) and "Accent MRI system (with MRI scan)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oklahoma Heart Institute" are 48 trials for "All" genders.

Currently, there are NaN active trials in "Oklahoma Heart Institute". undefined are not yet recruiting, 11 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Oklahoma Heart Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Oklahoma Heart Institute, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 29 trials that are defined as “Not Applicable".

Oklahoma Heart Institute has several departments that took part in Clinical trials: "Oklahoma Heart Institute at Hillcrest Medical Center" - 3 trials, "Oklahoma Cardiovascular And Hypertension Center" - 3 trials